ClinicalTrials.gg
Sign In

Asphyxia Neonatorum clinical trials

The registry lists 106 studies for Asphyxia Neonatorum across more than 10 countries. 19 are recruiting or about to start. 65 of them are mainly about Asphyxia Neonatorum (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Asphyxia Neonatorum studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
63
Recruiting
15
Status unknown
12
Withdrawn
6
Not yet recruiting
4
Active, not recruiting
4

Phase

Phase 3
11
Phase 1
7
Phase 2
7
Early Phase 1
1
Phase 4
1

Where

United States
15
Canada
11
Italy
8
India
8
Uganda
7
Turkey
6

Who runs them

Imperial College London (5) · Sharp HealthCare (4) · Aga Khan University (3) · University of California, San Francisco (3) · Nemours Children's Clinic (3) · University of Alberta (3) · NICHD Global Network for Women's and Children's Health (3) · Pia Wintermark (2)

What is being tested here

Drugs under test in Asphyxia Neonatorum studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Sildenafil126
Erythropoietin124
RLS-0071111
Sovateltide101
Cytidine Diphosphate Choline111
Magnesium Sulfate002
Vitamin E001
Ascorbic Acid001
Amikacin001
Oxygen011

Coming up

4phase 3 studies under way
7studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 7, phase 3 first

Who these studies take

Of the 15 Asphyxia Neonatorum studies recruiting now, 3 (20%) set no upper age limit and 12 (80%) stop at 75 or younger. 15 (100%) take children under 18. 2 (13%) are for women only and 0 (0%) for men only; 2 (13%) take healthy volunteers.

Recruiting studies that take each age, of 15
AgeWomenMen
103 (20%)1 (7%)
183 (20%)1 (7%)
303 (20%)1 (7%)
403 (20%)1 (7%)
503 (20%)1 (7%)
653 (20%)1 (7%)
753 (20%)1 (7%)
853 (20%)1 (7%)

Across all 106 studies, recruiting or not: 75% stop at 75 or younger and 75% at 65; 87% take children; 13% are for women only and 0% for men only; 26% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Asphyxia Neonatorum studies take

Of 33 interventional studies with no phase under Asphyxia Neonatorum, half reached primary completion within 15 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase15 mo8–34 · 33 studies—15 mo8–34 · 33 studies
Observational32 mo14–47 · 16 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 106. Browse all 106 → or search them.